PIKFYVE and embryonal carcinoma: Finally, the ability of PIFYVE inhibitors to selectively eliminate pluripotent embryonal carcinoma stem cells from teratocarcinomas suggests that PIKFYVE inhibitors have therapeutic potential in treating germ cell neoplasia and in preventing spontaneous tumor formation from embryonic stem cells and induced pluripotent stem cells used in targeted gene therapy [8].